DETAILING STORY FUTURE- DAY 1

© Mankind Pharma 2020, All rights reserved.

COMPANY INTRODUCTION Nurokind Morning Sir, PAGE 1 I am ……………………………… from Future Mankind, a Mankind © Mank©inMd aPnhkairnmdaP2h0a2rm0,aA2ll0r2ig0h, tAsllrerisgehrtvserde.served. Group of Company. • Sir Mankind feels great pleasure to inform you that we have started Operations in USA with Office in New Jersey. • Sir, supported by 18000 employees and medical fraternity with 21 manufacturing units, Mankind is Rank No.1 as per P/D/M. However, value wise the rank is 4th, this clearly shows that Mankind product range is affordable. • Sir, Mankind has built world-class R & D center at Manesar - NCR; backed by 350 experienced scientists. The focus areas of research are: API development: Sir, we feel proud to share that we are the 1st company in India and 2nd in the world to develop Dydrogesterone API. • Sir, I feel proud to share the opening of 21st Manufacturing unit and recently one of our manufacturing unit III has received USFDA approval • Sir, for last 24 years we at Mankind is bringing medicines at very affordable prices. • Sir, we need your blessings and support for Future Mankind as well. © Mankind Pharma 2020, All rights reserved.

© Mankind Pharma 2020, All rights reserved.